通过ATRP用于脑药物输送的PEGylated脂质体
Lulu Chen1, Zhenfang Zhang1, Maria R Simonsen1
1Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Odense, Denmark.
Journal of liposome research
|April 7, 2025
概括
这项研究引入了一种使用原子转移激素聚合 (ATRP) 制造PEGylated脂质体的新方法. 这种技术确保了统一的PEG覆盖,改善了药物输送到大脑和增强稳定性.
科学领域:
- 生物技术是生物技术.
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
背景情况:
- 基化脂质体对于药物输送至关重要,避免免疫检测.
- 传统的合成方法产生不一致的PEG分布,损害了脂质体的稳定性和性能.
- 目前PEGylated脂质体合成的局限性阻碍了它们的治疗潜力.
研究的目的:
- 开发一种新的,可控的方法来合成PEGylated脂质体.
- 改进PEG分布,增强药物输送的脂质体功能.
- 评估这种针对大脑的药物输送新方法的有效性.
主要方法:
- 使用基于脂质的启动剂来形成脂质体.
- 采用原子转移激素聚合 (ATRP) 进行可控的PEG链接接种.
- 合成的聚合物移植脂质体具有均的PEG覆盖.
主要成果:
- 合成ATRP的PEG化脂质体在体外显示出优异的细胞吸收率.
- 与传统的脂质体相比,证明了血脑屏障 (BBB) 的透能力提高.
- 在体内表现出更好的稳定性,特别是对于像GFP这样的蛋白质封装配方.
- 活/死测定证实了合成脂质体的生物相容性.
结论:
- 基于ATRP的策略提供了可控和均的脂质体PEGylation.
- 这种方法显著提高了脂质体的功能,用于向的大脑药物输送.
- 通过改善药物输送,为治疗神经系统疾病提供了一个有前途的平台.
相关概念视频
Drug Delivery: Parenteral Route
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


